8-K/A: Palomino Labs Completes Vega Links Acquisition, Files Financials

Palomino Laboratories Inc. has filed an amendment to its Form 8-K to include the financial statements of its newly acquired subsidiary, Vega Links, Inc., detailing the share exchange and pro forma combined financial information.

Summary

• Palomino Laboratories Inc. filed an amendment to its Form 8-K to provide the audited financial statements of Vega Links, Inc. and pro forma combined financial information following the acquisition.
• The acquisition of Vega Links, Inc. was completed on July 31, 2026, through a share exchange where Palomino issued 4,472,000 shares of its common stock.
• Vega Links, Inc. was a development-stage technology company incorporated on January 21, 2026, with no revenue-generating operations as of July 30, 2026.
• Vega Links reported a net loss of $16,346 and had total assets of $75,946 and total liabilities of $90,455 as of July 30, 2026.
• The pro forma condensed combined balance sheet as of June 30, 2026, shows total assets of $21,164,912 and total liabilities of $758,058.
• The pro forma condensed combined statements of operations show a net loss of $4,734,187 for the six months ended June 30, 2026, and a net loss of $10,855,778 for the year ended December 31, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the significant accumulated deficit and the initial lack of revenue for Vega Links, Inc., despite the acquisition by Palomino Laboratories Inc.

Positives

• Palomino Laboratories Inc. has successfully completed the acquisition of Vega Links, Inc., integrating its technology development into its operations.
• Palomino Laboratories Inc. has sufficient cash reserves (approximately $17.4 million as of October 14, 2026) to fund Vega Links' development costs for at least twelve months post-acquisition.
• The acquisition is expected to result in synergies and leverage Palomino's assembled workforce.
• Vega Links' net operating loss carryforwards of approximately $11,532 (federal) and $10,732 (California) may provide future tax benefits.

Negatives

• Vega Links, Inc. was a development-stage company with no revenue-generating operations as of July 30, 2026.
• Vega Links incurred a net loss of $16,346 for the period from inception (January 21, 2026) through July 30, 2026.
• As of July 30, 2026, Vega Links had total liabilities of $90,455, exceeding its total assets of $75,946, resulting in a stockholders deficit of $14,509.
• The pro forma combined entity shows significant accumulated deficits: $6,299,593 as of June 30, 2026, and $10,855,778 for the year ended December 31, 2025.
• The fair value of Palomino's common stock used in the acquisition was determined by an independent valuation firm using a Level 3 input, indicating significant unobservable inputs.
• A substantial portion of the acquisition consideration ($16,875,379) is attributed to post-combination services, recognized as stock-based compensation expense.

Risks

• Vega Links is subject to risks common to early-stage companies, including completing technology development, rapid technological change, and competition.
• Dependence on key personnel and service providers for Vega Links' development activities.
• Protection of intellectual property is a key risk for Vega Links.
• Future dependence on third-party foundries and suppliers for semiconductor connectivity technology.
• Global macroeconomic conditions, including inflation, interest rates, and geopolitical events, could delay development or increase costs.
• The preliminary purchase price allocation may change, potentially impacting goodwill and other assets/liabilities.
• The Strategic Development Agreement with Palomino was terminated, indicating a shift in how development costs are managed.
• The company has no credit facility or other committed third-party source of financing for Vega Links on a standalone basis.

Future Outlook

The filing primarily provides historical financial information for Vega Links and pro forma combined statements. Palomino Laboratories Inc. has indicated it has sufficient cash to fund Vega Links' development for at least twelve months. The Strategic Development Agreement was terminated, with Palomino now directly funding Vega Links' development.

Management Comments

• Management has concluded that Palomino's funding alleviates the substantial doubt about the Company's ability to continue as a going concern for at least twelve months from the date these financial statements are available to be issued.
• Palomino has funded the Company's development costs since the closing and has approximately $17.4 million cash, which is sufficient to fund the Company's requirements for at least twelve months.

Industry Context

StockSavvy.ai notes that this filing reflects a common strategy in the semiconductor and technology sectors where larger companies acquire smaller, innovative development-stage firms to bolster their product pipelines. The significant pro forma losses highlight the high-risk, high-reward nature of investing in early-stage technology development.

Comparison to Industry Standards

• The acquisition method of accounting used is standard for business combinations under U.S. GAAP.
• The valuation of IPR&D (In-Process Research and Development) is a common practice in the pharmaceutical and technology sectors, though its valuation can be highly subjective.
• The use of Level 3 inputs for fair value determination, as seen in Palomino's stock valuation, is typical for early-stage private companies or those with illiquid stock, but it introduces higher uncertainty compared to Level 1 or Level 2 inputs.
• The substantial stock-based compensation recognized as part of the acquisition consideration is consistent with industry practices for retaining key talent and incentivizing performance post-acquisition.

Management Changes

Related Party Transactions

• Loan from shareholder (CEO) of $25,000 to Vega Links, Inc., non-interest-bearing, due on demand.
• CEO paid patent registration costs of $1,930 on behalf of Vega Links, Inc., reimbursable and non-interest-bearing.
• Consulting agreements with officers and directors of Vega Links, Inc., involving restricted stock purchases.
• CEO purchased 5,000,000 shares of restricted common stock at $0.0001 per share.
• Special advisor purchased 2,500,000 shares of restricted common stock at $0.01 per share.
• Chief Product Officer purchased 1,850,000 shares of restricted common stock at $0.01 per share.

Stakeholder Impact

• Shareholders of Vega Links, Inc. received 4,472,000 shares of Palomino Laboratories Inc. common stock in exchange for their Vega Links shares.
• Some Vega Links shareholders agreed to a three-year lock-up on their Palomino shares.
• Certain Vega Links shareholders had their restricted stock awards modified, with some vesting accelerated and others subject to a shorter vesting period.
• Employees of Vega Links may transition to employment with Palomino Laboratories Inc., with their stock awards assumed.
• Creditors of Vega Links, Inc. are subject to the company's liabilities, which were assumed in the acquisition.

Next Steps

• Palomino Laboratories Inc. will continue to fund Vega Links' development activities directly.
• The company will finalize the purchase price allocation within one year of the closing date.
• Goodwill and intangible assets will be reviewed for impairment at least annually.

Key Dates

Recommendation

The acquisition of Vega Links by Palomino Laboratories Inc. is a strategic move, but the significant accumulated losses and the development-stage nature of Vega Links present considerable risk. While Palomino has sufficient funding to support Vega Links' development, the path to profitability is uncertain. Therefore, a 'hold' recommendation is appropriate, pending further clarity on the combined entity's revenue generation and path to profitability.

Keywords

Acquisition, Share Exchange, Financial Statements, Pro Forma, Semiconductor Technology, Development Stage, Stock-Based Compensation, Goodwill